Tumor Board Reviewing the Use of PSMA PET in Prostate Cancer Gleason 4+4=8 GG 4, PI-RADS 5 Lesion, Possible Seminal Vesicle Involvement - Session 2 Case 2 - H Jacene, A Kibel, P Nguyen, & A Morgans
Michael Hofman on Twitter: "Introducing the new PRIMARY score for reporting PSMA PET: using intra-prostatic PSMA PET/CT patterns to optimise prostate cancer DIAGNOSIS. We feel this is MAJOR advance for interpretation of
PSMA-RADS Version 1.0: A Step Towards Standardizing the Interpretation and Reporting of PSMA–targeted PET Imaging Studies
JCM | Free Full-Text | Recent Updates on Molecular Imaging Reporting and Data Systems (MI-RADS) for Theranostic Radiotracers—Navigating Pitfalls of SSTR- and PSMA-Targeted PET/CT
Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET | EJNMMI Research | Full Text
AUA 2021: PSMA-Targeted PET Imaging and Interpretation: What Urologists Need to Know
Michael Hofman on Twitter: "Introducing the new PRIMARY score for reporting PSMA PET: using intra-prostatic PSMA PET/CT patterns to optimise prostate cancer DIAGNOSIS. We feel this is MAJOR advance for interpretation of
Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings | Cancer Imaging | Full Text
Table 1 from Proposal for a Structured Reporting System for Prostate-Specific Membrane Antigen–Targeted PET Imaging: PSMA-RADS Version 1.0 | Semantic Scholar
Stefan W. Czarniecki on Twitter: "PSMA-RADS Version 1.0: A Step Towards Standardizing the Interpretation and Reporting of PSMA–targeted PET Imaging Studies: https://t.co/qEZT2aapox @michael_gorin @radiolobt #prostatecancer https://t.co/BO983mYXdE ...
![PSMA-targeted [18F]DCFPyL PET/CT-avid lesions in a patient with prostate cancer: Clinical decision-making informed by the PSMA-RADS interpretive framework - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2214442018303577-egi10LGC7V9QWW.jpg "PSMA-targeted [18F]DCFPyL PET/CT-avid lesions in a patient with prostate cancer: Clinical decision-making informed by the PSMA-RADS interpretive framework - ScienceDirect")
PSMA-targeted [18F]DCFPyL PET/CT-avid lesions in a patient with prostate cancer: Clinical decision-making informed by the PSMA-RADS interpretive framework - ScienceDirect
Factors Predicting Metastatic Disease in 68Ga-PSMA-11 PET–Positive Osseous Lesions in Prostate Cancer | Journal of Nuclear Medicine
Cancers | Free Full-Text | Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CT
ECR: PSMA-RADS 1.0 validated in prostate cancer patients
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET | SpringerLink
Prostate-specific Membrane Antigen PET in Prostate Cancer | Radiology
Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls | RadioGraphics
Cureus | Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography: A Practical Guide for Radiologists and Clinicians | Article
JCM | Free Full-Text | Recent Updates on Molecular Imaging Reporting and Data Systems (MI-RADS) for Theranostic Radiotracers—Navigating Pitfalls of SSTR- and PSMA-Targeted PET/CT
Cureus | Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography: A Practical Guide for Radiologists and Clinicians | Article
Table 1 from PSMA-RADS Version 1.0: A Step Towards Standardizing the Interpretation and Reporting of PSMA-targeted PET Imaging Studies. | Semantic Scholar
Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET | EJNMMI Research | Full Text
